Simayla Pharmaceuticals

Simayla Pharmaceuticals is a South African pharmaceutical company specializing in the marketing and distribution of high-quality generic and branded medicines. The company has established a strong market presence in several key therapeutic areas, most notably women's health, central nervous system (CNS) disorders, and anti-infectives. In 2014, Simayla was acquired by the global pharmaceutical major Lupin, which utilized the acquisition to significantly expand its footprint in the South African market, particularly in the oral contraceptives segment. The company provides affordable healthcare solutions to both the private and public sectors in South Africa. Its portfolio includes a wide range of essential medications, including treatments for cardiovascular and respiratory conditions.